My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Femara 2.5 mg film-coated tablets



Originalis B.V.PPA2306/001/001

Main Information

Trade NameFemara 2.5 mg film-coated tablets
Active SubstancesLetrozole
Dosage FormFilm-coated tablet
Licence HolderOriginalis B.V.
Licence NumberPPA2306/001/001

Group Information

ATC CodeL02BG04 letrozole

Status

License statusAuthorised
Licence Issued14/09/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0013/080/001.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListLetrozole 2.5mg Film-coated Tablets
Interchangeable List CodeIC0117-018-003
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print